Show simple item record

dc.creatorMoore A.
dc.creatorHurley K.
dc.creatorMoore S.A.
dc.date.accessioned2022-09-26T18:58:47Z
dc.date.available2022-09-26T18:58:47Z
dc.date.issued2022
dc.identifier.urihttps://doi.org/10.1016/j.jdcr.2022.07.035
dc.identifier.urihttps://repository.tcu.edu/handle/116099117/55761
dc.languageen
dc.publisherElsevier
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceJAAD Case Reports
dc.subjectbasal cell carcinoma
dc.subjectclinical research
dc.subjectdrug response
dc.subjectgeneral dermatology
dc.subjectmedical dermatology
dc.subjectnonmelanoma skin cancer
dc.subjectoncology
dc.subjecttirbanibulin
dc.subjecttopical
dc.titleRapid resolution of recalcitrant basal cell carcinoma of the ear with topical tirbanibulin
dc.typeArticle
dc.rights.holder2022 by the American Academy of Dermatology
dc.rights.licenseCC BY-NC-ND 4.0
local.collegeBurnett School of Medicine
local.departmentBurnett School of Medicine
local.personsMoore (SOM)


Files in this item

Thumbnail
This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/